Clinical Trials Logo

Clinical Trial Summary

An Open-Label, 2-Way, 2-Period Crossover Study of Orally Administered VS-6766 in Healthy Adult Subjects to Determine the Effect of Food on the Pharmacokinetics of VS-6766


Clinical Trial Description

This is an open-label, randomized, 2-way, 2-period crossover, Food Effect study. On Day 1 of each period, subjects will receive a single oral dose of VS-6766 administered in a 2-way crossover fashion either under fasting conditions or following a standardized high-fat/high-calorie meal. PK sampling for VS-6766 will be collected predose and postdose. There will be a washout period between doses. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05187169
Study type Interventional
Source Verastem, Inc.
Contact Kate Adams
Phone 781-469-1038
Email [email protected]
Status Recruiting
Phase Phase 1
Start date December 16, 2021
Completion date February 15, 2022

See also
  Status Clinical Trial Phase
Completed NCT04501640 - A Study to Investigate the Effect of Food With Mirabegron in Healthy Chinese Participants Phase 4
Completed NCT01224587 - Magnetic Marker Monitoring (MMM) Study With Gel Matrix Tablets Under Fasting and Fed Conditions Phase 1
Withdrawn NCT02560363 - A Study to Compare the Pharmacokinetics of Different Formulations of AZD9977 and the Influence of Food in Healthy Male Subjects Phase 1
Completed NCT02017236 - A Food Effect Phase I Study of the Volitinib in Healthy Subjects Phase 1
Completed NCT03150498 - A Food Effects Study and Optional Multi Dose Study to Assess PK of BTD-001 Phase 1
Completed NCT01686217 - A Phase I Study to Compare 3 Different Strengths of an Extended Release Formulation of ASP015K to an Immediate Release Formulation of ASP015K Phase 1
Completed NCT01322464 - Study to Assess Food Effect on Sativex Bioavailability Phase 1
Completed NCT03885778 - A Food Effect Study of Besifovir in Healthy Subjects Phase 4